Bydureon Price Decoded: Insurance, Coupons, and Cash-Pay Options

Bydureon at a glance:

• Drug class: GLP-1 receptor agonist
• Manufacturer: AstraZeneca
• FDA approved: 2012
• Route: subcutaneous injection (single-dose pen)
• Typical frequency: once weekly
• Half-life: approximately 2 weeks (extended-release formulation)
• Cash price (US): $700-$800/month without insurance
• Receptor target: GLP-1 receptor

Bydureon pricing is one of those topics where the official "list price" and what people actually pay are two different conversations. The cash price runs $700-$800/month without insurance. Below we walk through the real options.

Bydureon Cash Price

Without insurance, Bydureon runs $700-$800/month without insurance in the US market.

That number is the starting point — what you actually pay depends on:

• Insurance status (commercial, Medicare, Medicaid, uninsured)
• Manufacturer savings programs (where applicable)
• Discount cards (GoodRx, Cost Plus Drug, manufacturer cards)
• Telehealth bundling (some platforms include the drug in a flat monthly fee)
• Pharmacy choice (chain vs independent vs mail-order)

Insurance Coverage

Coverage for Bydureon depends on the specific plan and the indication being treated. For FDA-approved indications, prior authorization is the most common gate. For off-label use, coverage is generally not available.

The pattern across the GLP-1 / metabolic medication space is: coverage for diabetes is widespread, coverage for weight loss is improving but still inconsistent, and coverage for any off-label use is rare.

Manufacturer Programs

AstraZeneca runs savings programs for eligible patients. Eligibility usually requires commercial insurance and an active prescription. Patients on Medicare or Medicaid generally aren't eligible.

Cash-Pay and Direct-from-Manufacturer Options

Several manufacturers have introduced direct-to-consumer cash channels for their GLP-1 products in response to coverage gaps. These can lower the cash price meaningfully — see our guide to getting GLP-1 medications for current options.

Total Cost Over a Year

A monthly price of $700-$800/month without insurance translates to roughly $10,800-$18,000 per year out of pocket without insurance. That's a real number to plan around — many programs that look attractive at $200/month for the first three months reset to full price after the introductory window.

For weight management, the relevant question is whether to plan around long-term use; for GLP-1 medications, weight regain after stopping is well-documented.

Comparing to Alternatives

Most patients now favor Trulicity, Ozempic, or Mounjaro over Bydureon for tolerability and efficacy. Some of those alternatives may be cheaper, covered when Bydureon isn't, or just better-suited for a particular case. See our cost comparison pages: linked above.

Bottom Line

Bydureon cost decisions deserve a real planning session — not a back-of-envelope guess. The annual numbers add up fast.

Frequently Asked Questions

Related Reading

• Bydureon: The Complete 2026 Guide (Mechanism, Dosing, Cost)
• Bydureon Side Effects: The Complete List and How to Handle Them
• What Results Should You Expect from Bydureon? A Practical Guide
• Does Bydureon Actually Cause Weight Loss? An Evidence Review
• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile

Sources

• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.
• Marso SP et al. Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (SUSTAIN-6). NEJM 2016;375:1834.
• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.

Pricing changes frequently. The numbers on this page reflect publicly available information as of 2026-04-29 and should be verified at the point of purchase.